Constraint-Induced Movement Therapy Plus Sensory Components After Stroke

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Aug 23, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a type of therapy called Constraint-Induced Movement Therapy (CI Therapy) to help people who have had a stroke improve the use of their affected arm and hand. The therapy focuses on getting patients to use their weaker limb more often in daily activities by providing intensive training and support. This trial is particularly interesting because it adds new techniques to also address sensory issues, which can affect how well a person feels and uses their arm after a stroke. The researchers believe that by combining this sensory training with the CI Therapy, participants can see even better improvements in their arm function.

To be eligible for this trial, participants must be at least six months post-stroke and show some ability to move their affected arm, like being able to lift their shoulder or move their elbow. They also need to demonstrate limited use of their affected arm in daily life. However, individuals who have significant cognitive difficulties or cannot come to the treatment facility will not be included. For those who participate, they can expect a structured program that involves both movement and sensory training over several days, aimed at helping them regain better function and use of their arm in everyday situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • At least 6 months post stroke
• • The ability to demonstrate the minimum UE active movement criteria of shoulder ≥ 30 toward flexion or abduction, initiate movement at the elbow for flexion and extension, and initiate movement at the wrist, fingers, or thumb.
• • Mean score of \<2.5 on the Motor Activity Log/ G4/5 Motor Activity Log indicating the participant's use of the more-affected UE.
• Exclusion Criteria:
• • Score\< 24 on the Mini Mental State Exam
• • Inability to answer the MAL/ G4/5 MAL questions and/or provide informed consent
• • The inability to come in to the laboratory setting for treatment.